Equities

Medicenna Therapeutics Corp

MDNA:TOR

Medicenna Therapeutics Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)1.57
  • Today's Change0.08 / 5.37%
  • Shares traded34.61k
  • 1 Year change+265.12%
  • Beta1.0906
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in CADView more

In 2024, cash reserves at Medicenna Therapeutics Corp fell by 16.61m. Cash Flow from Financing was even, which indicates that this company's capital needs are balanced. In addition the company used 16.26m for operations while cash used for investing totalled .
Cash flow per share-0.3681
Price/Cash flow per share--
Book value per share0.2603
Tangible book value per share0.2596
More ▼

Balance sheet in CADView more

Medicenna Therapeutics Corp has little financial risk as the capital structure does not rely on leverage.
Current ratio11.40
Quick ratio--
Total debt/total equity0.0088
Total debt/total capital0.0087
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.